Opioids + serotonergic medicines interaction: risk of serotonin syndrome

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1919卷 / 1期
关键词：
D O I：
10.1007/s40278-022-20946-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [11] LISURIDE AND LSD - DOPAMINERGIC AND SEROTONERGIC INTERACTIONS IN THE SEROTONIN SYNDROME
    SILBERGELD, EK
    HRUSKA, RE
    PSYCHOPHARMACOLOGY, 1979, 65 (03) : 233 - 237
  • [12] Venlafaxine interactionFirst report of an interaction with concomitant herbal medicines leading to serotonin syndrome: case report
    Reactions Weekly, 2004, 1016 (1) : 18 - 19
  • [13] INTERACTION OF GABA AND SEROTONIN IN THE ANXIOLYTIC ACTION OF DIAZEPAM AND SEROTONERGIC ANXIOLYTICS
    LOPEZRUBALCAVA, C
    SALDIVAR, A
    FERNANDEZGUASTI, A
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) : 433 - 440
  • [14] A Rare Case of Serotonin Syndrome With Buprenorphine and Other Serotonergic Medications
    Biedlingmaier, Andrew J.
    Koola, Maju Mathew
    Shad, Mujeeb U.
    John, Sajiny
    Reddy, Geetha G.
    Varghese, Sajoy P.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (04) : 379 - 381
  • [15] Incidence of Serotonin Syndrome in Patients Treated with Fentanyl on Serotonergic Agents
    Koury, Katharine M.
    Tsui, Becky
    Gulur, Padma
    PAIN PHYSICIAN, 2015, 18 (01) : E27 - E30
  • [16] Serotonin Syndrome Caused by Fentanyl Without Other Serotonergic Agents
    Salguero, Bertin
    Stevens, Gizelle
    Kinniry, Paul
    CHEST, 2016, 150 (04) : 460A - 460A
  • [17] Risk of serotonin syndrome in acutely ill patients receiving linezolid and opioids concomitantly: a retrospective cohort study
    Mitwally, Hassan
    Saad, Mohamed Omar
    Alkhiyami, Dania
    Fahmi, Amr Mohamed
    Mahmoud, Sara
    Al Hmoud, Eman
    El Enany, Rasha
    Younis, Hassan
    Mohammed, Shaban
    Rouf, Palli Abdul
    Thomas, Binny
    Al Hail, Moza
    IJID REGIONS, 2022, 5 : 137 - 140
  • [18] Opioids may bind protein targets associated with the serotonin syndrome
    Burkhart, Keith K.
    Abernethy, Darrell
    CLINICAL TOXICOLOGY, 2015, 53 (04) : 349 - 349
  • [19] Moclobemide and the risk of serotonin toxicity (or serotonin syndrome)
    Gillman, K
    CNS DRUG REVIEWS, 2004, 10 (01): : 83 - 85
  • [20] HEALTHCARE UTILIZATION AND COSTS OF SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC AGENTS
    Xie, L.
    Wang, Z.
    Alley, S.
    Baser, O.
    Nguyen, C.
    VALUE IN HEALTH, 2015, 18 (03) : A114 - A114
12345